Johan Spetz

15PUBLICATIONS
119CO-AUTHORS
Pharmaceutical delivery technologiesHaematologyRadiation therapyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 18, 2026
Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [177Lu]Lu-DOTATATE therapy.

|Jan 08, 2026
Platelet aging and desialylation increase apoptotic priming and BCL-XL dependence.

Renata Grozovsky, Cameron S Fraser, Xingping Qin

|Aug 12, 2025
Late apoptotic effects after treatment with 177Lu-octreotate in small-intestine neuroendocrine GOT1 tumor model.

Mikael Elvborn, Nishte Rassol, Daniella Pettersson

|Feb 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.

Veronica Rendo, Eudocia Q Lee, Connor Bossi

|Jul 20, 2023
Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX.

Rumani Singh, Stacey Yu, Marwa Osman

|Jan 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy.

Yi Sun, Or-Yam Revach, Seth Anderson

Pageof 3

Frequent Collaborators

8 joint publications

Kristopher A Sarosiek

6 joint publications

Xingping Qin

4 joint publications

Cameron S Fraser

3 joint publications

Eva Forssell-Aronsson